WallStreetZenWallStreetZen

NASDAQ: NAUT
Nautilus Biotechnology Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

NAUT earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$60.1M
Current Profit Margin
0%

NAUT Return on Equity

Current Company
-20.3%
Current Industry
15.6%
Current Market
-8.4%
NAUT's Return on Equity (-20.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NAUT announces earnings.

NAUT Return on Assets

Current Company
-17.9%
Current Industry
2.2%
NAUT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NAUT Return on Capital Employed

Current Company
-19.41%
Current Industry
17.7%

NAUT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NAUT$0.00-$55.02M-$60.06MN/AN/A
TRML$0.00-$61.09M-$62.78MN/AN/A
CDT$0.00-$7.55M-$7.41MN/AN/A
IGMS$1.85M-$224.51M-$238.30M+165.57%N/A
ORTX$21.84M-$66.59M-$72.92M+180.14%N/A
View Top Biotech Stocks

Nautilus Biotechnology Earnings & Revenue FAQ

What were NAUT's earnings last quarter?

On Invalid Date, Nautilus Biotechnology (NASDAQ: NAUT) reported Q3 2023 earnings per share (EPS) of -$0.13, up 18.18% year over year. Total Nautilus Biotechnology earnings for the quarter were -$15.88 million. In the same quarter last year, Nautilus Biotechnology's earnings per share (EPS) was -$0.11.

If you're new to stock investing, here's how to buy Nautilus Biotechnology stock.

What was NAUT's earnings growth in the past year?

As of Q4 2023, Nautilus Biotechnology's earnings has grown year over year. Nautilus Biotechnology's earnings in the past year totalled -$60.06 million.

What was NAUT's revenue last quarter?

On Invalid Date, Nautilus Biotechnology (NASDAQ: NAUT) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Nautilus Biotechnology's revenue was $0.00.

What was NAUT's revenue growth in the past year?

As of Q4 2023, Nautilus Biotechnology's revenue has grown null year over year. Nautilus Biotechnology's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.